logo BDSP

Base documentaire

  1. Childhood vaccination against chickenpox : an analysis benefits and costs.

    Article - En anglais


    To estimate the economic costs and benefits of routine childhood vaccination against varicella infection.


    Decision-analytic model of the incidence and costs of chickenpox in children assumed to receive varicella vaccine at age 15 months in conjunction with the measles-mumps-rubella vaccine, or not to be vaccinated against varicella.


    Hypothetical cohort of 100,000 children.

    Main outcome measures

    Costs of vaccination, cumulative incidence of chickenpox to age 25 years, and related disease costs, including medical treatment and work loss.


    Vaccination of 100,000 children against varicella at age 15 months would cost $4,812,000.

    Mots-clés Pascal : Varicelle, Virose, Infection, Vaccin, Vaccination, Enfant, Homme, Immunoprophylaxie, Etude statistique, Evaluation, Coût, Economie santé, Massachusetts, Etats Unis, Amérique du Nord, Amérique

    Mots-clés Pascal anglais : Varicella, Viral disease, Infection, Vaccine, Vaccination, Child, Human, Immunoprophylaxis, Statistical study, Evaluation, Costs, Health economy, Massachusetts, United States, North America, America

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 94-0535742

    Code Inist : 002B05C02A. Création : 199501.